Ginkgo Biloba
Ginkgo is used for cognition and may increase bleeding risk, complicating neurologic and procedural care.
Recommendation: Avoid around stroke, anticoagulants, or procedures unless clinician-approved.
Peptide ·Emerging evidence ·Reviewed May 2026
Cerebrolysin is a porcine-derived peptide mixture with neurotrophic-like activity, used in some countries for stroke, dementia, and traumatic brain injury. It is not FDA-approved in the United States. Meta-analyses and Cochrane reviews show mixed or uncertain clinical benefit, so import or wellness use should be avoided.
The bottom line
Evidence rating emerging. Most-documented uses: studied for acute ischemic stroke recovery, studied for vascular dementia and alzheimer disease, neurotrophic-like preclinical activity. 3 sources indexed (2017–2023), with 3 interaction records on file.
Core mechanism
Cerebrolysin contains low-molecular-weight peptides and amino acids proposed to mimic neurotrophic effects, reduce excitotoxicity, support synaptic plasticity, and modulate apoptosis in neural injury models. Clinical effects vary by indication and trial design. Because it is an injectable animal-derived biologic mixture, quality, hypersensitivity, and infection-control standards matter.1,2
Peptides are generally not reliably orally bioavailable unless a specific studied oral formulation is used. Human use of research-grade products is not appropriate.
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Regulated Injectable Cerebrolysin.
Research-market pricing is not a dosing recommendation; human use is not FDA-approved unless specifically stated. Updated 2026-06-04.
Dose: International trial protocols only1,3
Timing: Hospital or rehab protocol
Do not delay emergency stroke care.
Dose: No FDA-approved US dose2
Timing: Specialist protocol
Evidence is mixed and diagnosis-specific.
Dose: No approved dose
Timing: Not applicable
Healthy-adult cognitive enhancement is not established.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Stroke trials and reviews exist but benefits are uncertain.3,1
Do not delay emergency treatment.
Dementia trials exist but evidence is limited and diagnosis-specific.2,3
Seek formal cognitive evaluation.
Neurotrophic rationale exists but evidence varies.
Use standard rehabilitation care.
Ginkgo is used for cognition and may increase bleeding risk, complicating neurologic and procedural care.
Recommendation: Avoid around stroke, anticoagulants, or procedures unless clinician-approved.
Fish oil may modestly increase bruising risk around injections or acute neurologic events.
Recommendation: Disclose use to clinicians before infusion or procedures.
St. John's Wort can affect mood and drug metabolism, complicating neurologic care.
Recommendation: Avoid combining with injectable neuroactive therapies without clinician review.
Numbered references. Citations throughout the page link here.
No clear all-cause mortality benefit
Small trials suggested possible cognitive effects
Efficacy outcomes were not consistently superior
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.